RSIP Vision develops AI module for 3D knee x-ray

Computer software and artificial intelligence (AI) company RSIP Vision has...Read more on AuntMinnie.comRelated Reading: RSIP Vision unveils new AI module for lung biopsy
Source: Headlines - Category: Radiology Source Type: news

Related Links:

With millions of people across the U.S. and the world battling COVID-19 infections, many of them struggling to breathe, ventilators have become a top priority for the health-care workers trying desperately to keep patients alive. And those machines, which help patients breathe or breathe for them, are in startlingly short supply. For doctors, resorting to a ventilator is an extreme measure, used when a patient’s lungs cannot supply enough oxygen on their own. Ventilators can also give a patient’s body time to rest when breathing is difficult, and allow doctors to more easily remove lung secretions or deliver me...
Source: TIME: Science - Category: Science Authors: Tags: Uncategorized COVID-19 feature Source Type: news
Transplant patients and people with lung diseases are among those who have been missed off the list.
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
(University of California - San Diego) With support from Amazon Web Services, UC San Diego Health physicians are using AI in a clinical research study aimed at speeding the detection of pneumonia, a condition associated with severe COVID-19.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
Consuetudinis magna vis est ( “Great is the power of habit”, Cicero, 106-43 BC)
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Commentary Source Type: research
AbstractLung transplantation during heparin-induced thrombocytopenia (HIT) is controversial and often considered a contraindication because of the risk of increased bleeding and thrombosis in the recipient. Although lung transplantation offers the best chance for cure in end-stage lung disease, the outcome after transplantation is still controversial in patients with HIT. In our center, two patients developed HIT type II during venovenous extracorporeal membrane oxygenation (ECMO) support for acute respiratory failure. They underwent successful lung transplantation using argatroban. The subsequent clinical course was uneve...
Source: General Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
Three otherwise healthy patients go to the emergency department with severe acute respiratory failure. Only one ventilator, required to sustain life until the worst of the coronavirus infection has passed, is available. Who gets the vent? That’s what “A Framework for Rationing Ventilators and Critical Care Beds During the COVID-19 Pandemic,” a Viewpoint just published in the Journal of the American Medical Association (JAMA), addresses. Douglas White, MD, MAS, Endowed Chair for Ethics in Critical Care Medicine at the University of Pittsburgh School of Medicine ...
Source: - Category: Medical Ethics Authors: Tags: Health Care Author: Lewis syndicated Source Type: blogs
The European Pediatric Pulmonary Vascular Disease Network (EPPVDN) investigated safety and efficacy of add-on selexipag, an oral IP prostacyclin receptor agonist approved for pulmonary arterial hypertension (PAH) in adults, in the largest, exploratory pediatric cohort to date.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Feature Article Source Type: research
For patients with advanced heart failure (HF), left ventricular assist device implantation as destination therapy (DT-LVAD) is potentially life prolonging, but comes with risks and burdens. Additionally, not all candidates will ultimately be medically appropriate for treatment due to various relative and absolute contraindications.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Research Correspondence Source Type: research
Background: Following transplant, cancer is a leading cause of morbidity and mortality. Human leukocyte antigen-G (HLA-G) – an immune checkpoint molecule – reduces allograft rejection by dampening host immune responses. Reports suggest malignant cells utilize HLA-G to evade the immune system and promote cancer development. Our objective was to evaluate HLA-G donor-recipient polymorphism matching and development of cancer following heart transplant. Methods: Recipients (n=251) and corresponding donors (n=196) were genotyped retrospectively to identify HLA-G polymorphisms in the 5’regulatory (–725, &n...
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Clinical Science Source Type: research
Ischemic heart disease remains the leading cause of mortality and morbidity worldwide despite improved possibilities in medical care. Alongside interventional therapies, such as coronary artery bypass grafting, adjuvant tissue-engineered and cell-based treatments can provide regenerative improvement. Unfortunately, most of these advanced approaches require multiple lengthy and costly preparation stages without delivering significant clinical benefits.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Pre-Clinical Science Source Type: research
More News: Computers | Lung Transplant | Radiology